Direct bidirectional μ-opioid control of midbrain dopamine neurons

Journal of Neuroscience

Volumn 34, Issue 44, 2014, Pages 14707-14716

  Margolis, Elyssa B ^a   Hjelmstad, Gregory O ^a   Fujita, Wakako ^b   Fields, Howard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium channel; Midbrain; Opioid; VTA

Indexed keywords

4 AMINOBUTYRIC ACID; CADMIUM CHLORIDE; CALCIUM CHANNEL BLOCKING AGENT; MU OPIATE RECEPTOR; OMEGA AGATOXIN IVA; PICROTOXIN; POTASSIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; NARCOTIC ANALGESIC AGENT;

ACTION POTENTIAL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EC50; ELECTROPHYSIOLOGY; HYPERPOLARIZATION; IMMUNOCYTOCHEMISTRY; MALE; MESENCEPHALON; NONHUMAN; POSTSYNAPTIC INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENTRAL TEGMENTUM; AGONISTS; ANIMAL; DRUG EFFECTS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; DOPAMINERGIC NEURONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; MESENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 84908355562     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2144-14.2014     Document Type: Article

References (65)

1. Bonci A, Malenka RC (1999) Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 19:3723-3730. Medline
2. Bonci A, Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803. Medline
3. Bozarth MA, Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551-555. CrossRef Medline
4. Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516-517. CrossRef Medline
5. Brischoux F, Chakraborty S, Brierley DI, Ungless MA (2009) Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci U S A 106:4894-4899. CrossRef Medline
6. Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815-834. CrossRef Medline
7. Cameron DL, Wessendorf MW, Williams JT (1997) A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77:155-166. CrossRef Medline
8. Cardozo DL, Bean BP (1995) Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. J Neurophysiol 74:1137-1148. Medline
9. Charles AC, Mostovskaya N, Asas K, Evans CJ, Dankovich ML, Hales TG (2003) Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory. Mol Pharmacol 63:89-95. CrossRef Medline
10. Chieng B, Azriel Y, Mohammadi S, Christie MJ (2011) Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol 589:3775-3787. CrossRef Medline
11. Dever SM, Xu R, Fitting S, Knapp PE, Hauser KF (2012) Differential expression and HIV-1 regulation of ÷-opioid receptor splice variants across human central nervous system cell types. J Neurovirol 18:181-190. CrossRef Medline
12. Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M (2010) Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30:218-229. CrossRef Medline
13. Ford CP, Mark GP, Williams JT (2006) Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26:2788-2797. CrossRef Medline
14. Ford CP, Phillips PE, Williams JT (2009) The time course of dopamine transmission in the ventral tegmental area. J Neurosci 29:13344-13352. CrossRef Medline
15. Garzón M, Pickel VM (2001) Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41:311-328. CrossRef Medline
16. Georgoussi Z, Leontiadis L, Mazarakou G, Merkouris M, Hyde K, Hamm H (2006) Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu-and delta-opioid receptors regulate opioid receptor signaling. Cell Signal 18:771-782. CrossRef Medline
17. Harrison C, Smart D, Lambert DG (1998) Stimulatory effects of opioids. Br J Anaesth 81:20-28. CrossRef Medline
18. Hjelmstad GO, Xia Y, Margolis EB, Fields HL (2013) Opioid modulation of ventral pallidal afferents to ventral tegmental area neurons. J Neurosci 33:6454-6459. CrossRef Medline
19. Iegorova O, Fisyunov A, Krishtal O (2010) G-protein-independent modulation of P-type calcium channels by mu-opioids in Purkinje neurons of rat. Neurosci Lett 480:106-111. CrossRef Medline
20. Jhou TC, Xu SP, Lee MR, Gallen CL, Ikemoto S (2012) Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat. Psychopharmacology 224:303-312. CrossRef Medline
21. Jiménez-González C, Pirttimaki T, Cope DW, Parri HR (2011) Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets delta-subunit-containing GABA(A) receptors. Eur J Neurosci 33:1471-1482. CrossRef Medline
22. Johnson SW, North RA (1992a) Opioids excite dopamine neurons by hy-perpolarization of local interneurons. J Neurosci 12:483-488. Medline
23. Johnson SW, North RA (1992b) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450:455-468. Medline
24. Jordan BA, Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700. CrossRef Medline
25. Kuszak AJ, Pitchiaya S, Anand JP, Mosberg HI, Walter NG, Sunahara RK (2009) Purification and functional reconstitution of monomeric muopioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem 284:26732-26741. CrossRef Medline
26. Lacey MG, Mercuri NB, North RA (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 392:397-416. Medline
27. Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, Deisseroth K, Malenka RC (2012) Input-specific control of reward and aversion in the ventral tegmental area. Nature 491:212-217. CrossRef Medline
28. Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29. CrossRef Medline
29. Malik RU, Ritt M, DeVree BT, Neubig RR, Sunahara RK, Sivaramakrishnan S (2013) Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells. J Biol Chem 288:17167-17178. CrossRef Medline
30. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ (1994) mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res 643:245-265. CrossRef Medline
31. Mansour A, Fox CA, Burke S, Akil H, Watson SJ (1995) Immunohisto-chemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8:283-305. CrossRef Medline
32. Margolis EB, Hjelmstad GO, Bonci A, Fields HL (2003)-Opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23:9981-9986. Medline
33. Margolis EB, Hjelmstad GO, Bonci A, Fields HL (2005) Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. J Neurophysiol 93:3086-3093. CrossRef Medline
34. Margolis EB, Lock H, Hjelmstad GO, Fields HL (2006) The ventral tegmen-tal area revisited: is there an electrophysiological marker for dopaminer-gic neurons? J Physiol 577:907-924. CrossRef Medline
35. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM (2008)-Opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28:12672-12681. CrossRef Medline
36. Margolis EB, Coker AR, Driscoll JR, Lemaître AI, Fields HL (2010) Reliabil-ity in the identification of midbrain dopamine neurons. PLoS One 5:e15222. CrossRef Medline
37. Margolis EB, Toy B, Himmels P, Morales M, Fields HL (2012) Identification of rat ventral tegmental area GABAergic neurons. PLoS One 7:e42365. CrossRef Medline
38. Matsui A, Williams JT (2011) Opioid-sensitive GABA inputs from rostro-medial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci 31:17729-17735. CrossRef Medline
39. Melis M, Camarini R, Ungless MA, Bonci A (2002) Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci 22:2074-2082. Medline
40. Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, Borea PA (2013) Mor-phine mediates a proinflammatory phenotype via ÷-opioid receptor-PKC-Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol 86:487-496. CrossRef Medline
41. Moaddab M, Haghparast A, Hassanpour-Ezatti M (2009) Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav Brain Res 198:466-471. CrossRef Medline
42. Moussawi K, Riegel A, Nair S, Kalivas PW (2011) Extracellular glutamate: functional compartments operate in different concentration ranges. Front Syst Neurosci 5:94. CrossRef Medline
43. Nader K, van der Kooy D (1997) Deprivation state switches the neurobio-logical substrates mediating opiate reward in the ventral tegmental area. J Neurosci 17:383-390. Medline
44. Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA (2008) Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, sub-stantia nigra and retrorubral field in the rat. Neuroscience 152:1024-1031. CrossRef Medline
45. Noda M, Nakanishi H, Akaike N (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92:1465-1474. CrossRef Medline
46. Olmstead MC, Franklin KB (1997) The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 111:1324-1334. CrossRef Medline
47. Omelchenko N, Sesack SR (2009) Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse 63:895-906. CrossRef Medline
48. Onali P, Olianas MC (1991) Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb. Mol Pharmacol 39:436-441. Medline
49. Patrick GA, Dewey WL, Spaulding TC, Harris LS (1975) Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. J Pharmacol Exp Ther 193:876-883. Medline
50. Puri SK, Cochin J, Volicer L (1975) Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum. Life Sci 16:759-767. CrossRef Medline
51. Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 34:209-220. CrossRef Medline
52. Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu-and kappa-opioid agonists. Brain Res 436:169-172. CrossRef Medline
53. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265:53-59. Medline
54. Steffensen SC, Stobbs SH, Colago EE, Lee RS, Koob GF, Gallegos RA, Henriksen SJ (2006) Contingent and non-contingent effects of heroin on mu-opioid receptor-containing ventral tegmental area GABA neurons. Exp Neurol 202:139-151. CrossRef Medline
55. Steinberg EE, Keiflin R, Boivin JR, Witten IB, Deisseroth K, Janak PH (2013) A causal link between prediction errors, dopamine neurons and learning. Nat Neurosci 16:966-973. CrossRef Medline
56. Theile JW, Morikawa H, Gonzales RA, Morrisett RA (2008) Ethanol enhances GABAergic transmission onto dopamine neurons in the ventral tegmental area of the rat. Alcohol Clin Exp Res 32:1040-1048. CrossRef Medline
57. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L, Deisseroth K (2009) Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324:1080-1084. CrossRef Medline
58. van Zessen R, Phillips JL, Budygin EA, Stuber GD (2012) Activation of VTA GABA neurons disrupts reward consumption. Neuron 73:1184-1194. CrossRef Medline
59. Velásquez-Martinez MC, Vázquez-Torres R, Jiménez-Rivera CA (2012) Activation of alpha1-adrenoceptors enhances glutamate release onto ventral teg-mental area dopamine cells. Neuroscience 216:18-30. CrossRef Medline
60. Wang Q, Liu-Chen LY, Traynor JR (2009) Differential modulation of mu-and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells. J Biol Chem 284:18357-18367. CrossRef Medline
61. Witten IB, Steinberg EE, Lee SY, Davidson TJ, Zalocusky KA, Brodsky M, Yizhar O, Cho SL, Gong S, Ramakrishnan C, Stuber GD, Tye KM, Janak PH, Deisseroth K (2011) Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 72:721-733. CrossRef Medline
62. Wong CS, Su YF, Watkins WD, Chang KJ (1994) Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5-yl imidodiphosphate. J Pharmacol Exp Ther 268:653-661. Medline
63. Xia Y, Driscoll JR, Wilbrecht L, Margolis EB, Fields HL, Hjelmstad GO (2011) Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 31:7811-7816. CrossRef Medline
64. Xiao C, Ye JH (2008) Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors. Neuroscience 153:240-248. CrossRef Medline
65. Zhang Y, Landthaler M, Schlussman SD, Yuferov V, Ho A, Tuschl T, Kreek MJ (2009) Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin. Neuroscience 158:474-483. CrossRef Medline